Fresh Tracks Therapeutics (FRTX) Q2 2023 Earnings

11AugConfirmed
Aug 22
Nov 22
Q4 2022
Q2 2023
-2.07
-1.38
-0.7
-0.01

Details

Expected EPS
N/A
Actual EPS
-0.39
Surprise EPS
-0.39
Surprise Percent
+∞%

Description

Fresh Tracks Therapeutics (FRTX) has reported earnings of -0.39 per share for Q2 2023.

0 Comments

Share your thoughts